1
项与 LUCAR-20SP(Nanjing Legend Biotech) 相关的临床试验A Phase I Clinical Study to Evaluate the Safety, Tolerability, and Efficacy of LUCAR-20SP, an Allogenic Chimeric Antigen Receptor(CAR)-T Cell Therapy Targeting CD20 in Subjects With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma
This is a prospective, single-arm, open-label, exploratory clinical study of LUCAR-20SP in adult subjects with relapsed/refractory B-cell non-Hodgkin lymphoma.
100 项与 LUCAR-20SP(Nanjing Legend Biotech) 相关的临床结果
100 项与 LUCAR-20SP(Nanjing Legend Biotech) 相关的转化医学
100 项与 LUCAR-20SP(Nanjing Legend Biotech) 相关的专利(医药)
100 项与 LUCAR-20SP(Nanjing Legend Biotech) 相关的药物交易